CN104407155B - 一种afp、gp73、pivka-ⅱ联合检测试剂盒 - Google Patents
一种afp、gp73、pivka-ⅱ联合检测试剂盒 Download PDFInfo
- Publication number
- CN104407155B CN104407155B CN201410736252.0A CN201410736252A CN104407155B CN 104407155 B CN104407155 B CN 104407155B CN 201410736252 A CN201410736252 A CN 201410736252A CN 104407155 B CN104407155 B CN 104407155B
- Authority
- CN
- China
- Prior art keywords
- antibody
- pivka
- afp
- test paper
- antagonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 73
- 101710123134 Ice-binding protein Proteins 0.000 title claims abstract description 72
- 101710082837 Ice-structuring protein Proteins 0.000 title claims abstract description 72
- 101710107540 Type-2 ice-structuring protein Proteins 0.000 title claims abstract description 72
- 108010063628 acarboxyprothrombin Proteins 0.000 title claims abstract description 67
- 102100021184 Golgi membrane protein 1 Human genes 0.000 title abstract description 16
- 101001040742 Homo sapiens Golgi membrane protein 1 Proteins 0.000 title abstract description 15
- 238000012360 testing method Methods 0.000 claims abstract description 74
- 201000000839 Vitamin K Deficiency Bleeding Diseases 0.000 claims abstract description 56
- 206010047634 Vitamin K deficiency Diseases 0.000 claims abstract description 56
- 208000016794 vitamin K deficiency hemorrhagic disease Diseases 0.000 claims abstract description 56
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 37
- 239000010931 gold Substances 0.000 claims abstract description 37
- 229910052737 gold Inorganic materials 0.000 claims abstract description 37
- 230000006698 induction Effects 0.000 claims abstract description 28
- 239000000020 Nitrocellulose Substances 0.000 claims abstract description 25
- 229920001220 nitrocellulos Polymers 0.000 claims abstract description 25
- 230000000274 adsorptive effect Effects 0.000 claims abstract description 7
- 102100023635 Alpha-fetoprotein Human genes 0.000 claims description 70
- 239000012530 fluid Substances 0.000 claims description 24
- 238000013016 damping Methods 0.000 claims description 21
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 20
- 239000000872 buffer Substances 0.000 claims description 20
- 239000007921 spray Substances 0.000 claims description 18
- 241001494479 Pecora Species 0.000 claims description 14
- 239000000243 solution Substances 0.000 claims description 13
- 238000002203 pretreatment Methods 0.000 claims description 12
- 239000004005 microsphere Substances 0.000 claims description 9
- 229930091371 Fructose Natural products 0.000 claims description 8
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 8
- 239000005715 Fructose Substances 0.000 claims description 8
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims description 8
- 229940037003 alum Drugs 0.000 claims description 8
- 239000007853 buffer solution Substances 0.000 claims description 8
- 239000001177 diphosphate Substances 0.000 claims description 8
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 claims description 8
- 235000011180 diphosphates Nutrition 0.000 claims description 8
- 235000013905 glycine and its sodium salt Nutrition 0.000 claims description 8
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 claims description 8
- 235000019982 sodium hexametaphosphate Nutrition 0.000 claims description 8
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims description 8
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 claims description 8
- 239000004471 Glycine Substances 0.000 claims description 6
- -1 alum Chemical compound 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 4
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims description 4
- 238000005520 cutting process Methods 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- GHCZTIFQWKKGSB-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O GHCZTIFQWKKGSB-UHFFFAOYSA-N 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 230000035945 sensitivity Effects 0.000 abstract description 12
- 238000005516 engineering process Methods 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 4
- 101800001271 Surface protein Proteins 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 238000004587 chromatography analysis Methods 0.000 abstract description 2
- 239000011806 microball Substances 0.000 abstract description 2
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 18
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 14
- 210000002966 serum Anatomy 0.000 description 13
- 201000007270 liver cancer Diseases 0.000 description 10
- 208000014018 liver neoplasm Diseases 0.000 description 10
- 238000003745 diagnosis Methods 0.000 description 9
- 101000860173 Myxococcus xanthus C-factor Proteins 0.000 description 8
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 7
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000011088 calibration curve Methods 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000003018 immunoassay Methods 0.000 description 4
- 206010073069 Hepatic cancer Diseases 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 108010077544 Chromatin Proteins 0.000 description 2
- 206010008909 Chronic Hepatitis Diseases 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- 102000004895 Lipoproteins Human genes 0.000 description 2
- 108090001030 Lipoproteins Proteins 0.000 description 2
- 108010026331 alpha-Fetoproteins Proteins 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000003483 chromatin Anatomy 0.000 description 2
- 230000007882 cirrhosis Effects 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 210000003754 fetus Anatomy 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 108050005430 Golgi membrane protein 1 Proteins 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000008118 PEG 6000 Substances 0.000 description 1
- 229920002538 Polyethylene Glycol 20000 Polymers 0.000 description 1
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- 229920002594 Polyethylene Glycol 8000 Polymers 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003150 biochemical marker Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 239000000439 tumor marker Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410736252.0A CN104407155B (zh) | 2014-12-05 | 2014-12-05 | 一种afp、gp73、pivka-ⅱ联合检测试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410736252.0A CN104407155B (zh) | 2014-12-05 | 2014-12-05 | 一种afp、gp73、pivka-ⅱ联合检测试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104407155A CN104407155A (zh) | 2015-03-11 |
CN104407155B true CN104407155B (zh) | 2016-01-13 |
Family
ID=52644801
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410736252.0A Active CN104407155B (zh) | 2014-12-05 | 2014-12-05 | 一种afp、gp73、pivka-ⅱ联合检测试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104407155B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107345969A (zh) * | 2016-05-05 | 2017-11-14 | 中国医学科学院基础医学研究所 | 包含afp、gp73和ceacam1的血清标记物在诊断肝脏疾病中的用途 |
CN109444422A (zh) * | 2018-12-17 | 2019-03-08 | 福建省立医院 | 一种基于upt-lf定量测定血清pivka-ii的检测卡及其构建方法及应用 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6893831B1 (en) * | 1999-12-14 | 2005-05-17 | Sanko Junyaku Co., Ltd. | Immunoassay of PIVKA-II |
CN101526534A (zh) * | 2009-03-10 | 2009-09-09 | 沈鹤柏 | 一种荧光免疫层析试纸及其制备方法和应用 |
CN102226779A (zh) * | 2011-03-28 | 2011-10-26 | 中国人民解放军第三军医大学第三附属医院 | 一种电化学免疫检测方法 |
CN102854324A (zh) * | 2012-08-17 | 2013-01-02 | 西北大学 | 快速无损伤性检测肝肿瘤标志物的方法以及采用的试纸条 |
CN102879559A (zh) * | 2011-07-12 | 2013-01-16 | 上海执诚生物科技股份有限公司 | 一种时间分辨荧光免疫层析即时定量检测试剂和方法 |
CN202757941U (zh) * | 2012-08-15 | 2013-02-27 | 沈阳医学院 | 基于纳米量子点技术的肝癌早期诊断生物试剂盒 |
CN103364550A (zh) * | 2013-07-16 | 2013-10-23 | 天津大学 | 用量子点标记的免疫层析试纸条快速定量检测肿瘤标志物的方法及装置 |
CN103529207A (zh) * | 2013-10-17 | 2014-01-22 | 天津中新科炬生物制药有限公司 | 多种肿瘤标志物快速定量联合检测装置 |
-
2014
- 2014-12-05 CN CN201410736252.0A patent/CN104407155B/zh active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6893831B1 (en) * | 1999-12-14 | 2005-05-17 | Sanko Junyaku Co., Ltd. | Immunoassay of PIVKA-II |
CN101526534A (zh) * | 2009-03-10 | 2009-09-09 | 沈鹤柏 | 一种荧光免疫层析试纸及其制备方法和应用 |
CN102226779A (zh) * | 2011-03-28 | 2011-10-26 | 中国人民解放军第三军医大学第三附属医院 | 一种电化学免疫检测方法 |
CN102879559A (zh) * | 2011-07-12 | 2013-01-16 | 上海执诚生物科技股份有限公司 | 一种时间分辨荧光免疫层析即时定量检测试剂和方法 |
CN202757941U (zh) * | 2012-08-15 | 2013-02-27 | 沈阳医学院 | 基于纳米量子点技术的肝癌早期诊断生物试剂盒 |
CN102854324A (zh) * | 2012-08-17 | 2013-01-02 | 西北大学 | 快速无损伤性检测肝肿瘤标志物的方法以及采用的试纸条 |
CN103364550A (zh) * | 2013-07-16 | 2013-10-23 | 天津大学 | 用量子点标记的免疫层析试纸条快速定量检测肿瘤标志物的方法及装置 |
CN103529207A (zh) * | 2013-10-17 | 2014-01-22 | 天津中新科炬生物制药有限公司 | 多种肿瘤标志物快速定量联合检测装置 |
Non-Patent Citations (1)
Title |
---|
biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy;Kai Zhu等;《Biomarker Research》;20131231;第1卷(第10期);第1-3页 * |
Also Published As
Publication number | Publication date |
---|---|
CN104407155A (zh) | 2015-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104360085B (zh) | 一种afp检测试剂盒 | |
Fan et al. | High-sensitive and multiplex biosensing assay of NSCLC-derived exosomes via different recognition sites based on SPRi array | |
Yu et al. | Disposable lateral flow-through strip for smartphone-camera to quantitatively detect alkaline phosphatase activity in milk | |
Huerta-Nuñez et al. | A biosensor capable of identifying low quantities of breast cancer cells by electrical impedance spectroscopy | |
Li et al. | An electrochemical biosensor for the assay of alpha-fetoprotein-L3 with practical applications | |
BRPI0411059A (pt) | tiras de teste diagnóstico para detecção de um analito de interesse em uma amostra lìquida, para detecção de anticorpo de anti-hiv em uma amostra, e de teste de gravidez de imuno-diagnóstico, e, método de detecção de um anticorpo de interesse em uma amostra lìquida | |
Yang et al. | Integrated microfluidic paper-based system for determination of whole blood albumin | |
NO20001126D0 (no) | Et ikke-angripende transdermalt system for Õ detektere analytter | |
CN105588944B (zh) | 检测agp1、serpina3和cdh1含量的***在筛查活动性结核病患者中的应用 | |
CN104407155B (zh) | 一种afp、gp73、pivka-ⅱ联合检测试剂盒 | |
CA2510377A1 (en) | Use of nicotinamide n-methyltransferase as a marker for colorectal cancer | |
Demirbakan et al. | A novel electrochemical immunosensor based on disposable ITO-PET electrodes for sensitive detection of PAK 2 antigen | |
CN104391122B (zh) | 一种afp、pivka-ⅱ联合检测试剂盒 | |
Ruivo et al. | Colorimetric detection of D-dimer in a paper-based immunodetection device | |
CN104459138B (zh) | 一种***结合蛋白-1检测试剂盒 | |
Ruiz-Vega et al. | Paper microfluidics on screen-printed electrodes for simple electrochemical magneto-immunosensor performance | |
Cavallaro et al. | Multiplexed electrokinetic sensor for detection and therapy monitoring of extracellular vesicles from liquid biopsies of non-small-cell lung cancer patients | |
JP2014531027A (ja) | 電気化学的分析 | |
Martínez-Mancera et al. | Pre-clinical validation study of a miniaturized electrochemical immunoassay based on square wave voltammetry for early detection of carcinoembryonic antigen in human serum | |
CN104360082B (zh) | 一种afp、gp73联合检测试剂盒 | |
CN104360080B (zh) | 一种高尔基体糖蛋白-73检测试剂盒 | |
CN104360079B (zh) | 一种pivka-ⅱ检测试剂盒 | |
CN104459140B (zh) | 一种定量检测类风湿因子、抗链球菌溶血素o、抗环瓜氨酸肽抗体、c反应蛋白的检测试剂盒 | |
CN104459115B (zh) | 一种gp73、pivka-ⅱ联合检测试剂盒 | |
Zhang et al. | Enumeration and molecular characterization of circulating tumor cell using an in vivo capture system in squamous cell carcinoma of head and neck |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160307 Address after: 200436, room 238, No. three, 406 Shanghai Road, Zhabei District, China Patentee after: Shanghai Rui Rui Biotechnology Co., Ltd. Address before: Jiulongpo Branch Park four street 400039 Chongqing city 70-1, 70-2 block J No. six Patentee before: CHONGQING QIANDE BIOTECHNOLOGY CO., LTD. |
|
CB03 | Change of inventor or designer information |
Inventor after: Ji Quan Inventor after: Wang Lianghua Inventor before: Pan Nengke |
|
COR | Change of bibliographic data | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180102 Address after: 400000 Taikang Road Dadukou District of Chongqing Bridge Industrial Park C District No. 6 Building 30 layer 1-4 Patentee after: Chongqing Zhongyuan Ji Ji Biological Technology Co., Ltd. Address before: Room 406, No. 238, three road, Zhabei District River, sea Patentee before: Shanghai Rui Rui Biotechnology Co., Ltd. |
|
TR01 | Transfer of patent right | ||
CP01 | Change in the name or title of a patent holder |
Address after: Floor 1-4, building 30, no.6, Taikang Road, Zone C, Jianqiao Industrial Park, Dadukou District, Chongqing 400000 Patentee after: Zhongyuan Huiji Biotechnology Co.,Ltd. Address before: Floor 1-4, building 30, no.6, Taikang Road, Zone C, Jianqiao Industrial Park, Dadukou District, Chongqing 400000 Patentee before: CHONGQING ZHONGYUAN HUIJI BIOTECHNOLOGY Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder |